Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease

被引：0
|
作者：
Kumarasinghe, G. [1 ,2 ]
Lavee, O. [1 ,2 ]
Parker, A. [1 ,2 ]
Keogh, A. [1 ,2 ]
Hayward, C. [1 ,2 ]
Kotlyar, E. [1 ,2 ]
Jabbour, A. [1 ,2 ]
Havryk, A. [1 ,2 ]
Malouf, M. [1 ,2 ]
Plit, M. [1 ,2 ]
Glanville, A. [1 ,2 ]
Macdonald, P. [1 ,2 ]
Moore, J. [1 ,2 ]
机构：
[1] St Vincents Hosp, Heart & Lung Transplant Unit, Sydney, NSW 2010, Australia
[2] St Vincents Hosp, Dept Haematol, Sydney, NSW 2010, Australia
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2013年 / 32卷 / 04期
关键词：
D O I：
10.1016/j.healun.2013.01.657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
700
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [31] Risk Factors Associated with Response to Rituximab Therapy in Allogeneic Stem Cell Transplant Patients with EBV viremia or Post-Transplant Lymphoproliferative Disease
    Carella, Beth
    Lehrman, Rachel
    Heller, Glenn
    Prockop, Susan
    BONE MARROW TRANSPLANTATION, 2018, 53 : 587 - 587
  • [32] Incidence and Clinical Outcomes of Post-Transplant Lymphoproliferative Disorder ( PTLD) in Lung Transplant Recipients
    Boyle, N.
    Winward, S.
    Lawrie, I
    Towell, S.
    Egan, J.
    Ronan, N.
    Murray, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S28 - S28
  • [33] Management and outcome of liver recipients with post-transplant lymphoproliferative disease
    Glez-Chamorro, A
    Jimenez, C
    Moreno-Glez, E
    Glez-Pinto, I
    Loinaz, C
    Gomez, R
    Garcia, I
    Alonso, O
    Palma, F
    Grande, C
    HEPATO-GASTROENTEROLOGY, 2000, 47 (31) : 211 - 219
  • [34] Post-transplant lymphoproliferative disease in pediatric solid organ recipients
    Wistinghausen, Birte
    CANCER INVESTIGATION, 2007, 25 : 63 - 64
  • [35] Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort
    Katz, B. Z.
    Pahl, E.
    Crawford, S. E.
    Kostyk, M. C.
    Rodgers, S.
    Seshadri, R.
    Proytcheva, M.
    Pophal, S.
    PEDIATRIC TRANSPLANTATION, 2007, 11 (01) : 58 - 65
  • [36] Epstein-Barr virus-associated risk factors for post-transplant lymphoproliferative disease in pediatric liver transplant recipients
    Quintero Bernabeu, Jesus
    Juamperez, Javier
    Mercadal-Hally, Maria
    Larrarte King, Mauricio
    Gallego Melcon, Soledad
    Gros Subias, Luis
    Sabado Alvarez, Constantino
    Soler-Palacin, Pere
    Melendo Perez, Susana
    Esperalba, Juliana
    Navarro Jimenez, Alexandra
    Garrido Pontnou, Marta
    Camacho Soriano, Jessica
    Hidalgo Llompart, Ernest
    Bilbao Aguirre, Itxarone
    Charco Torra, Itzarone
    PEDIATRIC TRANSPLANTATION, 2022, 26 (06)
  • [37] Post-transplant lymphoproliferative disorder: risk factors and management
    Malyszko, Jolanta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (07) : 1177 - 1179
  • [38] Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients
    Funch, DP
    Walker, AM
    Schneider, G
    Ziyadeh, NJ
    Pescovitz, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (12) : 2894 - 2900
  • [39] Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients
    Mahale, Parag
    Engels, Eric A.
    Lynch, Charles F.
    Morton, Lindsay M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (02) : 347 - 351
  • [40] Post-transplant lymphoproliferative disease - Association with induction therapy?
    Dharnidharka, VR
    DRUGS, 2006, 66 (04) : 429 - 438
12345